| Pueblo Springs Rehabilitation Center | |
| 5545 East Lee Street, Tucson, Arizona 85712 | |
| (520) 296-2306 | |
| Name | Pueblo Springs Rehabilitation Center |
|---|---|
| Location | 5545 East Lee Street, Tucson, Arizona |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 143 |
| Occupancy Rate | 52.38% |
| Medicare ID (CCN) | 035068 |
| Legal Business Name | Willow Canyon Healthcare Inc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1033365465 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1376706184 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE & REHABILITATION |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1417111949 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1508020033 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1548422785 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE & REHABILITATION |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1811220270 |
| Organization Name | QUINCE HOLDINGS, LLC |
| Doing Business As | PUEBLO SPRINGS REHABILITATION CENTER |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1861916686 |
| Organization Name | WILLOW CANYON HEALTHCARE LLC |
| Doing Business As | PUEBLO SPRINGS REHABILITATION CENTER |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1881858314 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1891955837 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE & REHABILITATION |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| NPI Number | 1972767408 |
| Organization Name | PEOPLEFIRST REHABILITATION |
| Doing Business As | VALLEY HEALTHCARE |
| Address | 5545 E Lee St, Tucson, AZ 85712 |
| Phone Number | 520-296-2306 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7150 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.82 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.65 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.19 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.91 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.09 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.34 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.21 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.61 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.91 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.98 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 42.45 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.08 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.8 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.84 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 51.61 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.53 | 82.93 |
News Archive
Italy is grappling with the coronavirus disease pandemic, which has ravaged the country since February. In just a month, the number of cases has reached more than 35,000. Over the past 24 hours, Italy has reported 475 additional deaths, increasing the death toll to a staggering 2,978, a few numbers away from Hubei Province's toll, the epicenter of the pandemic where the virus originated.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
› Verified 3 days ago
Santa Rosa Care Center Location: 1650 North Santa Rosa Avenue, Tucson, Arizona 85712 Phone: (520) 795-1610 | |
Handmaker Home For The Aging Location: 2221 North Rosemont Boulevard, Tucson, Arizona 85712 Phone: (520) 881-2323 | |
Foothills Rehabilitation Center Location: 2250 North Craycroft Road, Tucson, Arizona 85712 Phone: (520) 733-8700 | |
Pueblo Springs Rehabilitation Center Location: 5545 East Lee Street, Tucson, Arizona 85712 Phone: (520) 296-2306 | |
Casas Adobes Post Acute Rehab Center Location: 1919 West Medical Street, Tucson, Arizona 85704 Phone: (520) 297-8311 | |
Haven Of Saguaro Valley Location: 6651 East Carondelet Drive, Tucson, Arizona 85710 Phone: (520) 731-8500 |